MAM
CLDX icon

Meeder Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Meeder Asset Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-33
Closed -$1K – 2169
2022
Q2 		$1K Hold
33
– – ﹤0.01% 1993
2022
Q1 		$1K Hold
33
– – ﹤0.01% 2154
2021
Q4 		$1K Buy
+33
New +$1.44K ﹤0.01% 1013
2018
Q3 		– Sell
-126
Closed -$954 – 1561
2018
Q2 		$954 Buy
126
+88
+232% +$1.18K ﹤0.01% 1504
2018
Q1 		$1K Buy
38
+14
+58% +$542 ﹤0.01% 1443
2017
Q4 		$1K Buy
+24
New +$1.03K ﹤0.01% 1556
2017
Q3 		– Sell
-63
Closed -$2K – 1641
2017
Q2 		$2K Sell
63
-56
-47% -$2.48K ﹤0.01% 1388
2017
Q1 		$6K Sell
119
-230
-66% -$12K ﹤0.01% 996
2016
Q4 		$19K Buy
+349
New +$19.9K ﹤0.01% 663

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return